Guided nuclear missile for cancer: Telix prepares for Nasdaq IPO
Flushed with recent success, Melbourne-based, ASX-listed Telix Pharmaceuticals is looking to jointly list in the US to capitalise on its strong American base.
Andreas Kluge
Flushed with recent success, Melbourne-based, ASX-listed Telix Pharmaceuticals is looking to jointly list in the US to capitalise on its strong American base.